Publisher： Bentham Science Publishers
E-ISSN： 1875-533x|18|7|1050-1066
ISSN： 0929-8673
Source： Current Medicinal Chemistry, Vol.18, Iss.7, 2011-03, pp. : 1050-1066
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Nowadays, influenza virus is still a big threat to human. Hemagglutinin (HA) and neuraminidase (NA) are the two viral surface proteins, which play important roles in the life cycle of influenza virus. Current influenza vaccines and anti-influenza drugs work mainly by interfering with the functions of the two proteins. In this review, we will display some recent studies about the two proteins. As to HA, this review covers a lot including its fusion function, receptor specificity, antigenic shift hypothesis, novel antibodies and various inhibitors in order to deeply discuss this protein. As to NA, this review mainly focuses on studies about the newly identified 150-cavity of group-1 NAs and shows some untypical NA inhibitors aiming to provide a broader range of lead compounds for anti-influenza drug design.
Related content
Access to resources
Recommend
Structure and Functions of Influenza Virus Neuraminidase
Current Medicinal Chemistry, Vol. 14, Iss. 1, 2007-01 ,pp. :
Inhibitors Targeting the Influenza Virus Hemagglutinin
Current Medicinal Chemistry, Vol. 22, Iss. 11, 2015-04 ,pp. :
Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 4, 2007-01 ,pp. :